Casey Kopczynski News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Casey kopczynski. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Casey Kopczynski Today - Breaking & Trending Today

Aerie Pharmaceuticals' (AERI) CEO Raj Kannan on Q1 2022 Results - Earnings Call Transcript

Aerie Pharmaceuticals, Inc. (NASDAQ:NASDAQ:AERI) Q1 2022 Earnings Conference Call May 5, 2022 5:00 PM ET Company Participants Hans Vitzthum – LifeSci Partners Raj Kannan – Chief Executive. ....

United States , Serge Belanger , Oren Livnat , Raj Kannan , Stacy Ku , Gary Sternberg , Jeff Calabrese , Hans Vitzthum , Casey Kopczynski , Jason Gerberry , Bausch Lomb , Louise Chen , Annabel Samimy , Peter Lang , Carly Kenselaar , Yigal Nochomovitz , Company Participants , Head Of Research , Aerie Pharmaceuticals Inc , American Glaucoma Society , American Society Of Cataract , Needham Company , Association For Research , Aerie Pharmaceuticals , Conference Call May , Chief Executive ,

Aerie Pharmaceuticals, inc (AERI) Q3 2021 Earnings Call Transcript

AERI earnings call for the period ending September 30, 2021. ....

San Antonio , United States , Thomasa Mitro , Tom Mitro , Jason Gerberry , David Hollander , John Larocca , Annabel Samimy , Annabel Samimy Stifel , Greg Fraser Truist , Davida Hollander , Jeff Calabrese , Casey Kopczynski , Johnw Larocca , Benjaminf Mcgraw , Louise Chen , Francois Brisebois , Louise Chen Cantor , Greg Fraser , Francois Brisebois Oppenheimer , Ben Mcgraw , Ashwin Bank , Bus Partnership , Aerie Pharmaceuticals Third Quarter , Ken Cacciatore Of Cowen Company , Company Analyst ,

Aerie Pharmaceuticals Announces Presentations at the 2021 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting

Published: Apr 28, 2021

DURHAM, N.C. (BUSINESS WIRE) Aerie Pharmaceuticals, Inc.. (NASDAQ: AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma, ocular surface diseases and retinal diseases, today announced it will participate and have poster presentations at the virtual Association for Research and Vision in Ophthalmology (ARVO) Annual Meeting, to be held May 1-7, 2021. The posters will highlight topics ranging from additional research findings on netarsudil to potential new product candidates such as the new class of corticosteroid anti-inflammatories.
The following posters are independent research and not sponsored by Aerie Pharmaceuticals: ....

United States , Nate Goergen , Kevin Carbajal , Vladislav Bekerman , Reza Kianian , Maria Zaretskaia , Casey Kopczynski , Leslie Ramos , Natacha Villega , Timothy Janetos , Schepens Eye Research Institute Of Massachusetts , University Of Nebraska Medical Center , Aerie Pharmaceuticals Inc , Drug Administration , Northwestern University Feinberg School Of Medicine , Exchange Commission , European Medicines Agency , Tertiary Care Center , Association For Research , Stanford University , Aerie Pharmaceuticals , Annual Meeting , Northwestern University Feinberg School , Adjunctive Use , Refractory Glaucoma , Retrospective Analysis ,

Aerie Pharmaceuticals Announces Presentations at the 2021 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting

Press release content from Business Wire. The AP news staff was not involved in its creation.
Aerie Pharmaceuticals Announces Presentations at the 2021 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
April 28, 2021 GMT
DURHAM, N.C. (BUSINESS WIRE) Apr 28, 2021
Aerie Pharmaceuticals, Inc. (NASDAQ: AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma, ocular surface diseases and retinal diseases, today announced it will participate and have poster presentations at the virtual Association for Research and Vision in Ophthalmology (ARVO) Annual Meeting, to be held May 1-7, 2021. The posters will highlight topics ranging from additional research findings on netarsudil to potential new product candidates such as the new class of corticosteroid anti-inflammatories. ....

United States , Nate Goergen , Kevin Carbajal , Vladislav Bekerman , Reza Kianian , Maria Zaretskaia , Casey Kopczynski , Leslie Ramos , Natacha Villega , Timothy Janetos , Schepens Eye Research Institute Of Massachusetts , University Of Nebraska Medical Center , Aerie Pharmaceuticals Inc , Drug Administration , Northwestern University Feinberg School Of Medicine , Exchange Commission , European Medicines Agency , Tertiary Care Center , Association For Research , Stanford University , Aerie Pharmaceuticals , Annual Meeting , Northwestern University Feinberg School , Adjunctive Use , Refractory Glaucoma , Retrospective Analysis ,